Acutus Medical achieves second milestone under agreement with Medtronic

Acutus Medical (AFIB) announced that the Company has achieved the second milestone under the asset purchase agreement with Medtronic (MDT) of its left-heart access portfolio with the submission for CE Mark of this portfolio under European Union Medical Device Regulations, or MDR. This milestone triggers a $17M earnout payment from Medtronic to Acutus. "We are very pleased to have achieved this important milestone ahead of schedule. This submission is a critical step in our partnership with Medtronic, and we are confident that Medtronic will be able to accelerate adoption and positive impact on patient care and physician practice," said David Roman, President & CEO of Acutus Medical. "In addition to positioning the left-heart access portfolio for long-term success in Europe, achieving this key milestone bolsters our financial position and enables Acutus to continue to focus on our differentiated mapping and therapy platform."